Ozempic-class drugs are showing surprising benefits beyond obesity — from reducing cancer risk to potentially curbing violent impulses.
Category: Blog
Your blog category
Why Nuclear Spending Hit a Record $119 Billion in 2025
Nine nuclear-armed nations spent nearly 20% more on nuclear weapons last year as global tensions surged, raising arms race fears.
Lessons From India’s Education Reform Crisis
Student protests across 20 Iranian provinces and India’s NEET re-exam controversy highlight a global reckoning over exam fairness and AI-proof testing.
How the World Cup Became a Showcase for Football Diaspora
Palestinian-American, Iranian-American, and other diaspora communities are finding voice and identity through the 2026 World Cup.
Brahmin Unease and the Future of Indian Politics
Growing discontent among upper-caste communities in Uttar Pradesh could reshape electoral dynamics ahead of state elections.
FMCG Giants Are Recalibrating in the Age of AI Marketing
Major consumer goods companies are rethinking advertising strategies as AI-powered personalisation upends traditional brand-building.
India Must Build Institutional Resilience to Absorb Global Shocks
Analysts argue India’s economic resilience needs stronger institutional frameworks to withstand future geopolitical crises like the Iran war.
Capital Gains Tax in India: Why It Doesn’t Deserve a Special Status
Economists debate whether India’s preferential capital gains treatment is justified amid calls for tax equity in a high-growth economy.
The Case for Swimming Over Running for Heart Health
New research finds swimming matches running for fitness gains but delivers superior heart muscle growth, offering a compelling alternative.
Cursor Acquisition Shows Why AI Coding Tools Are Now Worth More Than Traditional Software Companies
A tech commentator argued that SpaceX’s $60 billion acquisition of Cursor proves that AI coding tools are fundamentally reshaping what software companies are worth in the modern era.